Breast Density

Breast density, or fibroglandular density, is found through breast imaging and compares the amount of fat to the amount of tissue.

Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has signed an agreement with Invitae Corporation, a leader in medical genetics, to bring Invitae's genetic testing services to Volpara's customers in the United States.

News | Breast Imaging

Volpara Collaborates with Invitae Corporation for Genetic Testing Services

July 29, 2021 — Volpara Health, a global health technology software leader providing an integrated breast care platform ...

July 29, 2021

Volpara now holds 98 granted patents across 27 countries

News | Breast Imaging

Volpara Health Grows its Patent Collection

July 16, 2021 — Volpara has recently been granted another patent by the European Patent Office, raising the total number ...

July 16, 2021

According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

News | Breast Imaging

Routine Screening Return for BI-RADS 3 Lesions on Supplemental Automated Whole-Breast Ultrasound

July 16, 2021 —According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 ...

July 16, 2021

Sponsored Content

Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Case Study | Artificial Intelligence

From Surviving to Thriving: How Regional Medical Imaging Enhanced Productivity

As the largest independent imaging group in Michigan with 10 locations across the state, Regional Medical Imaging (RMI) ...

April 09, 2020

The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, according to a new JAMA Oncology study of nearly 30,000 patients led by researchers in the Basser Center for BRCA at the Abramson Cancer Center.

News | Women's Health

Black and White Women Have Same Mutations Linked to Breast Cancer Risk

June 15, 2021 — The prevalence of genetic mutations associated with breast cancer in Black and white women is the same ...

June 15, 2021

Kathryn A. Gold, M.D., associate clinical professor at University of California San Diego School of Medicine, presented data showing an increase in people diagnosed with advanced stage breast cancer in 2020 and 2021, compared to 2019.

News | Breast Imaging

Increase in Advanced Breast Cancer Diagnoses During COVID-19 Pandemic

June 8, 2021 — Reporting at the 2021 annual meeting of the American Society of Clinical Oncology, Kathryn A. Gold, M.D ...

June 08, 2021

Medical researchers at Flinders University have established a new link between high body mass index (BMI) and breast cancer survival rates — with clinical data revealing worse outcomes for early breast cancer (EBC) patients and improved survival rates in advanced breast cancer (ABC).

News | Women's Health

Decoding the Effect of Body Mass Index on Breast Cancer

May 13, 2021 — Medical researchers at Flinders University have established a new link between high body mass index (BMI) ...

May 13, 2021

Sponsored Content

Figure 1. R MLO view from four different years. The skin mole is marked with a circular skin marker (TomoSPOT REF# 782, Beekley Medical) on the far-left image. These images demonstrate the potential for significant variability in location of the skin lesion due to movability of the skin during positioning.

Case Study | Breast Imaging

Use of Mole Markers in DBT Improves Clinical Workflow and Patient Safety

Christina Jacobs, M.D., Director of Breast Imaging (Bronson Health System) is always looking for ways to work more ...

April 09, 2020

News | Women's Health

Hologic Launches $20M Initiative to Tackle Racial Disparities in Healthcare

May 12, 2021 — Hologic, Inc. launched Project Health Equality (PHE), a unique initiative that strives to address the ...

May 12, 2021

News | Artificial Intelligence

Breast Cancer AI Company Whiterabbit Receives FDA Clearance for WRDensity

May 11, 2021 — Whiterabbit, an AI technology company focused on early breast cancer detection, today announced the ...

May 11, 2021

Knowledge gaps regarding breast density among women’s health providers can be addressed with web-based education and may lead to more informed and effective patient-provider communications

News | Breast Density

DenseBreast-Info.org Research Published Identifying Important Knowledge Gaps in Breast Density

April 28, 2021 – DenseBreast-info.org (DB-I) announced the results of the study, “Effect of an educational intervention ...

April 28, 2021

Sponsored Content

Videos | Breast Density

Innovative Breast Cancer Screening for Women With Dense Breast Tissue

Monica Saini, M.D., consultant medical director — ABUS at GE Healthcare, discusses the necessity for personalized breast ...

January 09, 2017

The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

News | Breast Imaging

FDA Clears Imagio P200003 Breast Imaging System

April 23, 2021 — The U.S. Food and Drug Administration (FDA) has approved Seno Medical's Imagio P200003 Breast Imaging ...

April 23, 2021

iCad announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) was cleared by the U.S. Food and Drug Administration (FDA).

News | Breast Imaging

FDA Clears for ProFound AI Version 3.0 for 3D Mammography

March 23, 2021 — iCad announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) was cleared by the U ...

March 23, 2021

Left to right: Subtraction right mediolateral oblique (MLO) CEM was non-diagnostic because of artifact, potentially due to motion misregistration from extended exposure time; subtraction right MLO implant displaced CEM image shows 5.8 cm enhancing mass (arrow); contrast-enhanced MRI sagittal subtraction image shows concordant mass (arrow).

News | Breast Imaging

Contrast-Enhanced Mammography for Breast Cancer in Women With Augmented Breasts

March 18, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) showed ...

March 18, 2021

Sponsored Content

Case Study | Women's Health

Enhancing Precision, Growing Patient Volume, Fighting a Growing Public Health

Following the global trend, cancer rates in Mexico continue to rise — and breast cancer is now the number-one killer of ...

July 06, 2016

Attending the two most recent screening appointments before a breast cancer diagnosis protects against breast cancer death, according to a Queen Mary University of London study of over half a million Swedish women conducted over 24 years

News | Breast Imaging

Attending Consecutive Mammography Screens Protects Against Breast Cancer Death

March 12, 2021 — For women who had participated in both of their previous two screening examinations, the incidence of ...

March 12, 2021

Breast cancer is the most common fatal cancer in women. Early detection increases a woman's chances of recovery. Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue.

News | MRI Breast

Simple MRI Measurement Could Avoid 30% of Breast Biopsies

March 9, 2021 — Breast cancer is the most common fatal cancer in women. Early detection increases a woman's chances of ...

March 09, 2021

A comparison of standard mammography imaging (left) in a woman with dense breasts and a breast MRI imaging study (right) showing a clearly defined cancer and is extremely hard to detect on the mammograms.

Feature | MRI Breast | By Dave Fornell, Editor

Use of Breast MRI Screening in Women With Dense Breasts

Dense breast tissue can hide cancers in mammograms in about half of women. Supplemental imaging is often needed to ...

March 04, 2021

Researchers said women who skip even one scheduled mammography screening before a breast cancer diagnosis face a significantly higher risk of dying from the cancer.

News | Mammography

Skipping Mammogram Increases Risk of Death from Breast Cancer

March 3, 2021 — Attendance at regular mammography screening substantially reduces the risk of dying from breast cancer ...

March 03, 2021

55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned. #COVIDvaccine #COVID19

News | Breast Imaging

COVID-19 Vaccination Axillary Adenopathy Detected During Breast Imaging

February 24, 2021 — An open-access article in ARRS’ American Journal of Roentgenology (AJR) describes the clinical and ...

February 24, 2021

Breast Cancer Index added to National Comprehensive Cancer Network guidelines to predict benefit from extended endocrine therapy

News | Women's Health

Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market

February 23, 2021 — Hologic, Inc. has completed its previously announced acquisition of molecular oncology leader ...

February 23, 2021

Screening strategy based on baseline breast density at age 40 may be effective and cost-effective for reducing breast cancer mortality

News | Breast Density

Risk-based Breast Cancer Screening

February 10, 2021 — A mammography screening strategy based on a baseline breast density measure at age 40 may be the ...

February 10, 2021

Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).

News | Breast Imaging

Breast Cancer Death Rates Stop Declining in Younger Women

February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S. younger than age 40, ending a ...

February 10, 2021